Eli Lilly and Company
Eli Lilly and Company says the partnership will result in the development of the most powerful supercomputer owned by a pharmaceutical company.
The hub expands the company's research and development footprint in the region and hastens the development of AI-powered digital health technologies.
The collaboration will leverage Genetic Leap's RNA-targeted AI platform to create genetic medicines against selected targets.
Also: Sutter Health and Aetna's joint venture partners with house call startup Heal; SideKickHealth announces strategic partnership with Bayer.
These data provide a proof of concept that Apple products and other consumer devices can play a role in monitoring or identifying disease symptoms.
Pharma companies also continued to explore the promises of digital therapeutics.
Onduo, Livongo, Abbott and others also shared news at the show.
Lilly-funded study shows Livongo diabetes program can save employers $20 to $50 per member per month
The retrospective analysis compared more than 2,200 Livongo users with non-users at the same companies.
Also: Case Western Reserve University's rowing team will now wear VivaLNK's wearable patches and Memorial Sloan Kettering Cancer Center inks a deal with MyHealthDirect.